| 
          New Tools for Breast Cancer Risk Assessment         | 
              
          0.50         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Updates in Metastatic Colorectal Cancer         | 
              
          0.75         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Treatment Updates for Small Cell Lung Cancer         | 
              
          0.50         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Treatment for Pleural and Peritoneal Mesothelioma         | 
              
          0.75         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Advances in the Treatment of Non-Metastatic Non-Small Cell Lung Cancer         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Management of Immune Checkpoint Inhibitor-Related Toxicities         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Newer Approaches to Treatment of Bladder Cancer         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Team-Based Case Review: Oligometastatic Prostate, Non-Small Cell Lung, and Colorectal Cancers         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Smoking Cessation for Patients with Cancer: State of the Evidence         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          The Impact of Frontline Immune Checkpoint Inhibitors on Therapy for Relapsed/Refractory Hodgkin Lymphoma         | 
              
          0.75         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Updates to Management of Multiple Myeloma         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Best Practices for Oncology Urgent Care         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Expansion of Recommendations for Hereditary Cancers         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Updates in the Multidisciplinary Approach for Resectable Gastroesophageal Adenocarcinoma and Peritoneal-Limited Disease         | 
              
          1.00         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         | 
          
      
              | 
          Management of Advanced Gastroenteropancreatic Neuroendocrine Tumors         | 
              
          0.75         | 
              
          06/15/2025 - 12:00am to 03/01/2026 - 12:00am         |